| Course | FIN 660 Advanced Financial Strategies |
|---|---|
| Topic | Topic 7 |
| Paper type | Synergy and payment memo |
| Length | About 800 words, 1 pages |
| Format | Memo with APA 7 references |
| School | Grand Canyon University (GCU) |
| Program | MS in Finance |
| Updated | October 2026 |
Free sample paper for FIN 660 Topic 7
Memorandum
To: Board of Directors
From: Corporate Development
Date: [Date]
Re: Synergy evidence and form of payment for the proposed acquisition
The Question
Our bankers propose bidding 27 a share for a rival trading at 20, a premium of 35 percent, and support the price with synergies of 60 million dollars a year. This memo asks how much of the premium the evidence supports and who should bear the risk that some synergies never arrive. All figures are in millions and illustrative; the memo values synergies after a 25 percent tax at a 10 percent cost of capital.
Standalone Value First
The target has 50 million shares at 20, a market value of 1,000. Our own forecast for the target as a standalone business supports about the same figure, so the memo measures the premium from 1,000. At 27 a share the bid is 1,350 and the premium 350. Sirower (1997) argued that a premium is a promise of performance beyond what the target's price already expects, so the 350 must come entirely from synergies the target could not achieve alone.
The Synergy Line Rebuilt by Source
The bankers present the 60 a year as a single line. The memo rebuilds it by source and grades each by its evidence: contracted or mapped, estimated but not yet planned, or asserted.
Procurement savings of 24 a year are backed by supplier contracts that already offer volume tiers, and closing one of two overlapping plants saves 14 a year, with the closure plan drafted. Together, 38 before tax is 28.5 after tax, worth about 285 capitalized. Headcount savings of about 6.4 a year have not yet been mapped to roles and would begin in year three; after tax and the delay they are worth about 40. Cross-selling revenue contributes about 16 a year of margin on the bankers' own estimate, beginning in year two, worth about 110. Integration costs, mainly severance, systems and the plant closure, take 45.
Table 1
Claimed Synergies Graded by Evidence, Millions of Dollars
| Source | Annual, pre-tax | Value | Evidence grade |
|---|---|---|---|
| Procurement and plant | 38 | 285 | Contracted or mapped |
| Headcount | 6.4 | 40 | Estimated, not mapped |
| Cross-selling revenue | 16 | 110 | Asserted |
| Integration costs | | minus 45 | Estimated | |
| Net, all sources | About 60 | 390 |
The Premium Set Against Each Grade
Net of integration costs, firm evidence supports 240 of the 350 premium. Adding the estimated headcount savings brings support to 280. Only if every cross-selling claim holds does net synergy reach 390. So 70 of the premium rests on revenue the bankers have asserted, which requires about 64 percent of that revenue, 70 of its 110, to appear. Put another way, the bankers' price is safe only if most of the cross-selling they forecast happens on schedule, and nothing in the record of either company's past cross-selling shows that it would.
Revenue synergies are the least reliable kind, because they depend on customers' choices rather than the buyer's actions. Roll (1986) argued that bidders often overpay because they trust their own valuations more than the market's, and that the market's price of the target is a better estimate than the bidder's confidence suggests. The memo treats the asserted revenue as possible but not as something the premium should depend on.
Who Carries the Shortfall Under Each Payment
If the deal is paid in cash, our holders bear the whole difference between the premium and the synergy that arrives. At 280, they lose about 70; at 240, about 110. If the deal is paid in stock, target holders receive about 25 percent of the combined company, given our market value of about 4,050, and therefore bear about a quarter of any shortfall. At 280, our holders would lose about 52.5 and the target's about 17.5.
Travlos (1987) found that bidders paying in stock experienced significantly negative announcement returns while cash bidders did not, which is often read as the market inferring that stock-paying bidders think their own shares are overvalued. A stock component therefore carries a signaling cost. The memo weighs that cost against the risk sharing stock provides and limits the stock to the part of the price the evidence does not support.
Recommendation
The memo recommends an all-cash bid of up to 25.60 a share, the price at which the premium of 280 matches the synergy supported by contracted, mapped and estimated savings. If competition requires a higher bid, at least half of the amount above 25.60 should be paid in our shares, so the target's holders share the risk of the revenue synergy on which the higher price depends.
The board should also ask management to assign an owner and a date to each synergy source before signing, and to report progress against Table 1 quarterly after closing. A synergy no one owns is the first to slip, and the board will want to see which grade is delivering.
References
Roll, R. (1986). The hubris hypothesis of corporate takeovers. Journal of Business, 59(2), 197-216. https://doi.org/10.1086/296325
Sirower, M. L. (1997). The synergy trap: How companies lose the acquisition game. Free Press.
Travlos, N. G. (1987). Corporate takeover bids, methods of payment, and bidding firms' stock returns. Journal of Finance, 42(4), 943-963. https://doi.org/10.1111/j.1540-6261.1987.tb03921.x
Reading the GCU FIN 660 Topic 7 instructions
The Topic 7 brief in FIN-660 asks students to value an acquisition with synergies kept separate from standalone value. Strong memos fix the target's standalone value first, rebuild the claimed synergies by source with timing, tax and an evidence grade for each, and give integration costs their own line. Students should set the premium against what each grade supports, explain why bidders tend to overpay, and compare cash and stock payment at several synergy outcomes, showing who bears a shortfall, before recommending a price and form of payment.
How this FIN 660 Topic 7 example is built
The target's 50 million shares trade at 20 in the finished memo's illustrative case, a standalone value of 1,000 million that the memo checks against its own forecast; the bid of 27 pays a premium of 350. The bankers' 60 a year arrives as one line, so the memo rebuilds it by source and grades each by evidence. Savings backed by supplier contracts and two overlapping plants are worth about 285 after tax and phasing. Headcount savings not yet mapped to roles add 40. Cross-selling revenue, the bankers' own estimate, adds 110. Integration costs take 45. Net synergy is 240 on firm evidence, 280 with the headcount savings and 390 only if every revenue claim holds, so the premium needs about 64 percent of that revenue to appear.
Reading the FIN 660 Topic 7 rubric
Instructors reward a memo that grades every synergy by its evidence. An Excellent memo fixes standalone value at 1,000 and treats the premium, after Sirower, as a promise of performance. Credit goes to rebuilding the 60 a year into graded sources worth 285, 40 and 110, net of 45 in costs. The rubric values citing Roll's hubris argument and Travlos on stock-paying bidders. Strong memos show who bears a 70 shortfall under cash and under stock. Top marks go to a 25.60 cash ceiling with stock above it and owners named for each synergy.
FIN 660 Topic 7 help: mistakes that cost marks
Premiums defended with the bankers' synergy figure, repeated without a build, cost the most here, because nobody reading the memo can tell which savings exist and which are hoped for. Leaving integration costs out makes every synergy look free. Folding revenue claims in beside contracted savings, at the same weight, lets the weakest evidence carry as much of the price as the strongest. Measuring the premium from a price already lifted by takeover rumors understates what is being paid for. Choosing cash or stock without asking who bears the risk of a synergy shortfall leaves out the one decision the board can still adjust after the price is set. A recommendation that accepts 27 without stating the revenue it requires gives directors a number to approve and nothing to hold management to.
Get a FIN-660 Topic 7 example written to your instructions
Send the FIN-660 Topic 7 instructions and the rubric shared in your classroom, with the deal case your section assigns. We write a custom example to them, with standalone value fixed, each synergy built and graded by evidence, integration costs on their own line, the premium tested grade by grade and cash weighed against stock, in 24 to 48 hours. The first one is free.
More FIN 660 papers and MS in Finance samples
- FIN 660 Topic 1: Leveraged Recapitalization Assessment
- FIN 660 Topic 2: Buyout Debt Sizing Memo
- FIN 660 Topic 3: Dividend Cut Board Paper
- FIN 660 Topic 4: Distress Stage Assessment
- FIN 660 Topic 5: Divestiture Choice Dq Post
- FIN 660 Topic 6: Recovery Waterfall Analysis
- FIN 660 Topic 8: Cross-border Financing Board Paper
- FIN 210 Topic 7: Retirement Savings Projection
- FIN 655 Topic 7: Endowment Policy Statement
- FIN 350 Topic 7: Project Criteria Comparison
- FIN 490 Topic 7: Plan Consistency Review
FIN 660 Topic 7 questions, answered
How does paying in stock share synergy risk?
Target holders who take shares become owners of the combined firm, so if synergies fall short, part of the shortfall lands on them. In the example, paying 27 entirely in stock at 40 issues 33.75 million shares and gives target holders about 25 percent of the combined company. If net synergy stops at 280, the buyer's holders lose about 52 rather than the 70 they would lose paying cash.
What is the synergy trap?
Mark Sirower's name for the way acquirers overpay: the target's price already reflects the performance the market expects, so a premium is a commitment to deliver improvements beyond that, on a schedule, net of the cost of achieving them. When the premium is large relative to what the synergies can credibly produce, the buyer's holders lose even if the combined business performs well.
Would the memo's price hold for an actual deal?
No. Both companies, the synergy grades, the integration costs and the share prices are invented so that evidence and payment can be tested separately. Pricing an actual acquisition needs diligence findings, audited numbers, a real integration plan and the board's bankers and counsel. The memo is FIN-660 coursework on deal discipline and offers no view on any real transaction.
Where can I find a free FIN 660 Topic 7 sample paper?
The synergy memo is shown in full: the question, standalone value, the synergy line rebuilt by source, the premium against each grade, who carries the shortfall under each payment and the recommendation. Bring your deal's figures and a free memo can be prepared.
How is the 25.60 ceiling found in FIN 660 Topic 7?
Firm and estimated synergies support a premium of 280. Spread over 50 million shares, that is 5.60 a share above the unaffected price of 20, so cash bids above 25.60 rest on asserted revenue.